| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |